## Abstract A monoclonal antibody of the IgG class, EGFR1, has been isolated using cells of the epidermoid carcinoma line A431 as immunogen. The A431 antigen recognized by EGFR1 has an apparent molecular weight of approximately 175,000, is a cell‐surface molecule which can be specifically cross‐lin
Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site
✍ Scribed by Rita Pellegrini; Filippo Centis; Stefania Martignone; Antonio Mastroianni; Elda Tagliabue; Emanuela Tosi; Sylvie Ménard; Maria I. Colnaghi
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 815 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Spleen cells from BALB/c mice immunized with a plasma membrane-enriched fraction from rabbit sympathetic ganglia were Sused with the mouse myeloma NS 1. A hybrid clone was obtained that produced monoclonal antibody directed against the receptor for nerve growth factor (NGF). The antibody, identified
Monoclonal antibodies (McAbs) were developed that identify the complete (1-146 aa) and the NH2-terminal truncated (des 1-15) form of bovine basic fibroblast growth factor (bFGF). Four McAbs, designated McAbs 6, 8, 38, and 42, bind the complete form of bFGF found in bovine pituitary, brain, and adren
Approximately equal amounts of Iz51-mAb 225 (a monoclonal antibody recognizing the human e idermal growth factor receptor) and 1251-labeled epidermal growth factor (P251-EGF) were bound by HeLa cells. However, these two EGF receptor bindin moieties had different fates after binding. Sixty percent of